微信直播

体外膜肺氧合(ECMO):中外交流,聚焦热点

Published at: 2015年第1卷第S1期

钟珊珊
关键词:

编者按:近几年,体外膜肺氧合(ECMO)技术取得了显著的发展,它已成为常规治疗方法无效时,挽救成人和儿童严重心肺功能障碍的重要工具。不过总体而言,ECMO 在国内仍处于发展阶段,还存在着许多问题。在近日落幕的 The 24th Annual Meeting of ASCVTS & the 4th Asian Single Port VATS Symposium 大会上,多个 ECMO 专场围绕着对 ECMO 的进展、临床适应症、患者管理、插管选择和技术、并发症、预后等问题进行了探讨,会中我们也邀请了在 ECMO 技术有丰富经验的海内外专家讲者作了进一步分享。

 

 

受访专家

  • Paul G. Bannon MBBS, PhD, FRACS, Royal Prince Alfred Hospital, Sydney, Australia

  • Hsiao-Huang Chang, MD, PhD,Taipei Veterans General Hospital, Taiwan

 


图1.
 Prof. Paul G. Bannon和Prof. Hsiao-Huang Chang

 

采访问题

  1. How is the application of ECMO in your hospital?

  2. Would you like to share your experience and tips to better avoid the complications of ECMO?

  3. ECMO: routine treatment versus as life-saving treatment. 

 

访谈视频

 

 

受访专家

  • Kiran Shekar, MBBS, FCICM, FCCCM, PhD The Prince Charles Hopsital, Chermside, Australia

图2. Prof. Kiran Shekar报告剪影

 

采访问题

  1. Main points of your today’s presentation on ECMO. 

  2. For advanced-age patient, do you think it is appropriate to apply ECMO? 

  3. Talk about Patient selection for ECMO.

 

访谈视频

 

受访专家

  • I-Wen Wang, MD, PHD, FACS Indiana University Health Methodist Hospital of Indianapolis, Indianapolis, USA

  • 李平,武汉协和医院心外科

图3. Dr. I-Wen Wang和李平医生

采访问题

  1. Talk about the indications of ECMO

  2. How do you see the timing of application of ECMO support.

访谈视频

采访编辑丨钟珊珊,科学编辑,AME 出版社;

视频编辑丨麦雪芳,视频编辑,AME 出版社。

 

相关阅读:

 

doi:10.3978/kysj.2014.1.1880

comments powered by Disqus

附件